Chris Yamamoto
Optometrist · Honolulu, HINPI 1194863910
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,413 of the $8,199 with a category attached, or 66.0%. 15 manufacturers reported payments, led by Alcon at 51.2% of the total. Reporting peaked in 2023 at $2,677 and has fallen 68.7% since, to $839 in 2025. Among optometrist clinicians in HI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 75 payments — averaging $109.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$4K
- Bausch & Lomb Americas Inc.$1K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$900
- Coopervision Inc.$473
- AbbVie$329
- Tarsus Pharmaceuticals, Inc.$291
- plus $984 from 9 others
What the payments were for
- Travel & lodging$2,69233%
- Food & beverage$5,41366%
- Gifts$190%
- Entertainment$741%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 19 | $4,200 |
| Bausch & Lomb Americas Inc. | 10 | $1,023 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 11 | $900 |
| Coopervision Inc. | 7 | $473 |
| AbbVie(2 entities) | 13 | $329 |
| Tarsus Pharmaceuticals, Inc. | 5 | $291 |
| Dompe US, Inc. | 2 | $243 |
| Glaukos Corporation | 1 | $156 |
| LKC Technologies, Inc. | 1 | $121 |
| Shire North American Group Inc | 1 | $118 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $117 |
| Sight Sciences, Inc. | 1 | $117 |
| Optos, Inc. | 1 | $74 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Amgen | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INFUSE$952
- DAILIES$949
- AIR OPTIX$610
- BIOTRUE ONE DAY$595
- TOTAL30$400
- XDEMVY$253
- Oxervate$243
- ULTRA$236
- Tecnis IOL$235
- KXL System$156
- Photrexa$156
- INFUSE MULTIFOCAL$150
- INFUSE SVS$150
- LOTEMAX SM$125
- BTOD$125
- XIIDRA$118
- CATALYS SYSTEM$117
- OMNI(R) SURGICAL SYSTEM (US)$117
- VUITY$100
How this compares
$8,199 in reported general payments places this provider in the 95th percentile of 310 optometrist providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 11 | $94 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Honolulu
- Patricia IchimuraHonolulu$11K
- Lillian TakamuraHonolulu$11K
- Cherilyn LaiHonolulu$10K
- Brian TeruyaHonolulu$9K
- Derrick AbeHonolulu$9K
- Jennifer TeruyaHonolulu$9K
- Malia KuniokaHonolulu$9K
- Leslie PoonHonolulu$8K
- Rodney FongHonolulu$8K
- Nicole YokoyamaHonolulu$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.